Company Updates
SKYLECT wins three awards in 2021
SKYLECT, the immersive education network, is a state-of-the-art communication & learning platform aiming to establish a new paradigm for the utmost benefit of the business and education sectors. The p
Pictor Successfully Completes Validation Trial in U.S. for its SARS-Co-V-2 Antibody Test
New Zealand diagnostic biotech company Pictor Ltd. announced today that it has successfully completed validation trials at two separate sites in the United States, one of which was Florida-based Boca
Alternative Investment Platform Altive Co-leads Successful Series C Financing of US$ 120 Million for Swiss Digital Asset Bank SEBA
SEBA Bank AG has successfully completed its Series C financing on 12th Jan 2022. The successful financing round of CHF 110 million (US$ 120 million) was co-led by alternative investment platform Altiv
Issuer Pixel launches it’s 1-Click Sharing Features allowing instant Global Visibility
Issuer Pixel, a new video-centric B2B sharing and networking platform built on patented technology, recently took a significant leap ahead by unveiling its video and audio 1-Click sharing features. Si
Digital Health and Fintech Company Targets $7.9B Medical Alert Device Market
“Globally, 2.25 billion people live with chronic medical conditions, and this prevalence is increasing by 107 million a year.
Ezybandz is developing wearable medical alert devices to support perso
WealthLander Diversified Alternative Fund reports another positive-return month, which takes it to 20.7% return since inception
November delivered another positive return of 3.2%. Performance is 20.7% since inception on 1 February 2021 (assumes distribution reinvestment). Returns are net of all fees and costs. An investment in
All-in-One Mobile Platform for High-Yield Savings, Currency Exchange, and Cross-Border Payments | Operates in 120 Countries
“Prior to launch, the team is looking to make some strategic purchases, opening the scope of our permissions, capabilities and services.
We also have a time-sensitive opportunity to build out a tr
Positive Safety Data from Second Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights:
7 subjects in Cohort Two intravenously dosed; R327 subjects receiving 150mg meeting study end-points – indicating to be safe and well tolerated at this dose
Independent Safety Committee cl
Paysme complies with the main trends for FinTech in 2021
What investment themes are you focusing on for the year ahead?
A number of key themes emerged in FinTech during 2021 and they look set to continue well into 2022, including:
1. Embedded finance & supe
Backed By Leading Investment Groups and Family Offices
